<DOC>
	<DOCNO>NCT00351546</DOCNO>
	<brief_summary>Type 2 diabetes result body produce enough insulin and/or unable properly use insulin make ( insulin resistance ) . This study undertaken ass effect vildagliptin insulin sensitivity people type 2 diabetes .</brief_summary>
	<brief_title>A Study Assess Effects DPP-4 Inhibition Insulin Sensitivity Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diagnosed type 2 diabetes least 3 month prior screen Blood glucose criterion must meet On stable dose metformin therapy BMI le equal 39 Type 1 diabetes , diabetes result pancreatic injury secondary form diabetes Treatment thiazolidinediones use insulin within previous 3 month Significant illness within 2 week prior dose High fast triglyceride define protocol Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Vildagliptin</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Insulin sensitivity</keyword>
	<keyword>Insulin action</keyword>
</DOC>